HealthObesity Drug Ozempic's Pricetag Under Fire as Study Exposes Manufacturing Costs Recent research has raised concerns over the high prices of Novo Nordisk's obesity drug Ozempic despite low manufacturing costs.by QuincyJon
TechNissan Aims High Amid 'Extreme Market Volatility': Plans 30 New Models, 30% EV Cost Cutby Quincy Jon
ScienceProject Gaia Unveiled: Central Banks Utilize AI to Evaluate Climate Financial Risksby Quincy Jon
TechTikTok Uncertainty: Advertisers Eyeing Meta's Reels and YouTube's Shorts If US Senate Approves Banby Quincy Jon
TechPutin Warns: Russia Technically Ready for Nuclear War if U.S. Deploys Troops to Ukraineby Quincy Jon
WATCH: Runner Spends Year Using Exercise Tracker to Create Elaborate Stick Figure Art on City Streets